Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.

@article{Rappazzo2016RecombinantMO,
  title={Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.},
  author={C. Rappazzo and H. Watkins and C. Guarino and Annie Chau and J. Lopez and M. DeLisa and C. Leifer and G. Whittaker and D. Putnam},
  journal={Vaccine},
  year={2016},
  volume={34 10},
  pages={
          1252-8
        }
}
  • C. Rappazzo, H. Watkins, +6 authors D. Putnam
  • Published 2016
  • Biology, Medicine
  • Vaccine
  • Currently approved influenza vaccines predominantly protect through antibodies directed against the highly variable glycoprotein hemagglutinin (HA), necessitating annual redesign and formulation based on epidemiological prediction of predominant circulating strains. More conserved influenza protein sequences, such as the ectodomain of the influenza M2 protein, or M2e, show promise as a component of a universal influenza A vaccine, but require a Th1-biased immune response for activity. Recently… CONTINUE READING
    41 Citations
    Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV
    • 10
    • PDF
    Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.
    • 24
    • PDF
    Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine
    • 3
    Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses
    • PDF
    Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses
    • 47
    • Highly Influenced
    Lactobacillus plantarum displaying conserved M2e and HA2 fusion antigens induces protection against influenza virus challenge
    • 10
    Protective efficacy of Fc targeting conserved influenza virus M2e antigen expressed by Lactobacillus plantarum
    • 25
    • Highly Influenced

    References

    SHOWING 1-10 OF 40 REFERENCES
    Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus.
    • Min-Chul Kim, J. Song, +4 authors S. Kang
    • Biology, Medicine
    • Molecular therapy : the journal of the American Society of Gene Therapy
    • 2013
    • 107
    Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.
    • 39
    Universal influenza A vaccine: optimization of M2-based constructs.
    • 214
    • PDF